NHS at Cell 2026

Nov 12–13, 2026 London, UK ~800 attendees Website

NHS takes part in 4 sessions at Cell 2026 in London. Its program centres on why cell and gene therapies still struggle to reach patients after approval, and how hospitals can deliver them. Topics include running CAR-T trials in hospitals and growing advanced therapy capacity without compromising quality.

OrganizationCell 2026 Attendance
Gov/NGO
The UK's publicly funded health service, whose hospitals run clinical trials and deliver approved cell and gene therapies.
Panel
Thu Nov 12
5:45pm–6:10pm
Solving the Capacity Crunch: How Do We Scale Advanced Therapy Operations Without Compromising Quality?
Cell and gene therapyManufacturing and CMC
Panel
Fri Nov 13
2:45pm–3:10pm
From Approval To Access: Why Cell & Gene Therapies Still Don’t Reach Patients
with EMEUNET, John Radcliffe Hospital
Cell and gene therapy
Talk
Fri Nov 13
3:50pm–4:15pm
CAR-T Clinical Trials In Hospitals
Cell and gene therapy
Talk
Fri Nov 13
4:40pm–5:05pm
Patient Access In Hospitals To Administer Cell & Gene Therapies
Cell and gene therapy

Explore the full Cell 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full Cell 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from NHS

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction